Supporting high-quality cancer research projects in Europe

Swiss Bridge is a private foundation associated with the Swiss Cancer League, the Swiss Cancer Research foundation and the International Union Against Cancer (UICC), and supports high-quality cancer research in Europe. This year, eligible for funding are projects focusing on «Health Services Research in Oncology» with real life setting approaches (out of scope: cohort studies, pure data generation and registration, clinical studies, basic research). The results of those projects have to be generally valid (excluded are country-specific observations).

Investigators from academic and cancer research institutions in Europe are invited to submit a note of intent for a new cancer research project on or before 31th March, 2013. The proposals will be screened by an international scientific committee. The principal investigators of a shortlist of between 6 and 8 projects will then be invited to submit (by email) a detailed research application by the July 26th, 2013. Upon peer review and recommendation from the scientific committee, up to 3 projects will receive funding amounting to a total support of 500,000 Swiss Francs. The donors have earmarked part of it for an onco-paediatric project.

The winners will be invited to a ceremony to be held the first half of October 2013.

The note of intent should be no longer than 6 pages (3,000 words) and should include:

- the title of the project
- the name, address and affiliation of the principal investigator
- the domain of research (outcomes research, health economics, nursing sciences, epidemiology, public health, quality of life, other – please specify)
- the principal investigator’s short curriculum vitae
- a support letter from their employer
- the name(s), address(es) and affiliation(s) of the co-applicant(s)
- the project period (max. 3 years)
- the amount of financial support requested
- a summary of the project (1–2 pages)
- a list of up to 12 publications by the principal investigator and
- a statement regarding the impact on improving cancer specific health services in a real life setting (1–2 pages)

The note of intent must be transmitted by email on or before March 31st, 2013 to:

swissbridge@swisscancer.ch
Office of the Scientific Board of the Swiss Bridge Foundation
c/o Swiss Cancer League, P.O. Box 8219, CH-3001 Bern, Switzerland.

For more information, visit http://www.swissbridge.ch/en/annual-award/project-contribution.html